Research and Development Expense (Details) (USD $)			0 Months Ended
Dec. 31, 2012	Dec. 31, 2011	Aug. 23, 2012 Bristol-Myers Squibb Company FV-100
Research and Development Expense
Prepaid research and development costs	$ 926,380	$ 577,745
Asset Purchase Agreement
Initial payment in terms of agreement			1,000,000
Milestone of aggregate net sales			$ 125,000,000

Carrying amount, as of the balance sheet date, of payments made in advance for research and development costs, which will be charged against earnings within one year or the normal operating cycle, if longer.

No definition available.

Name:	sgyp_PrepaidResearchAndDevelopmentExpense
Namespace Prefix:	sgyp_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant